Iron overload in patients with chronic hepatitis C: a clinicopathologic study

Area of Science:

• Hepatology
• Gastroenterology
• Internal Medicine

Background:

• Hepatic iron overload has been suggested to negatively impact interferon therapy outcomes in chronic hepatitis C.
• Understanding iron levels in chronic hepatitis C is crucial for patient management and treatment efficacy.

Purpose of the Study:

• To determine the prevalence of iron overload in patients with chronic hepatitis C.
• To investigate the correlation between serum and hepatic iron concentrations and the activity and fibrosis of liver disease.

Main Methods:

• Retrospective review of records and liver biopsies from 72 chronic hepatitis C patients.
• Exclusion of patients with other liver disease causes or iron overload conditions.
• Assessment of necroinflammatory activity and fibrosis using the modified Knodell score and hepatic iron using Brissot's grading system.

Main Results:

• Increased serum iron (29%) and ferritin (43%) were observed.
• Hepatic iron grades 0, I, II, III, and IV were found in 37%, 35%, 25%, 3%, and 0% of patients, respectively.
• A significant correlation existed between hepatic iron grade and serum ferritin (P = .0001), but not with histological activity or fibrosis scores.

Conclusions:

• A substantial proportion of chronic hepatitis C patients exhibit mild to moderate hepatic iron increases, even after excluding common causes like alcoholism and transfusions.
• Severe hepatic iron overload was rare in this cohort.
• The study highlights the prevalence of hepatic iron in chronic hepatitis C but found no association with disease activity or fibrosis progression.